These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Taxonomy and Imaging Manifestations of Systemic Amyloidosis. Takahashi N; Glockner J; Howe BM; Hartman RP; Kawashima A Radiol Clin North Am; 2016 May; 54(3):597-612. PubMed ID: 27153791 [TBL] [Abstract][Full Text] [Related]
47. [Diagnosing cardiac amyloidosis in magnetic resonance imaging: The discriminating factors]. Goïorani F; Dagrenat C; Brocchi J; Couppie P; Leddet P Ann Cardiol Angeiol (Paris); 2020 Nov; 69(5):262-267. PubMed ID: 33067004 [TBL] [Abstract][Full Text] [Related]
48. Focal myocardial perfusion abnormalities in cardiac amyloidosis as compared with CMR, bone scintigraphy, and Ensako T; Norikane T; Yamamoto Y; Takami Y; Mitamura K; Maeda Y; Noma T; Nishiyama Y J Nucl Cardiol; 2021 Oct; 28(5):2408-2411. PubMed ID: 32909242 [No Abstract] [Full Text] [Related]
49. Tissue Doppler imaging and contrast-enhanced cardiac magnetic resonance in primary cardiac amyloidosis. Smedema JP; James R Eur J Echocardiogr; 2009 Dec; 10(8):984-6. PubMed ID: 19749196 [TBL] [Abstract][Full Text] [Related]
50. Amyloid PET imaging in cardiac amyloidosis: a pilot study using Dietemann S; Nkoulou R Ann Nucl Med; 2019 Aug; 33(8):624-628. PubMed ID: 31140154 [TBL] [Abstract][Full Text] [Related]
51. Diagnosis of cardiac amyloidosis based on the myocardial velocity profile in the hypertrophied left ventricular wall. Oki T; Tanaka H; Yamada H; Tabata T; Oishi Y; Ishimoto T; Nagase N; Shinohara H; Sakabe K; Fukuda N Am J Cardiol; 2004 Apr; 93(7):864-9. PubMed ID: 15050490 [TBL] [Abstract][Full Text] [Related]